{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T12:03:27Z","timestamp":1771589007424,"version":"3.50.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.juro.2013.01.104","type":"journal-article","created":{"date-parts":[[2013,2,8]],"date-time":"2013-02-08T22:46:01Z","timestamp":1360363561000},"page":"608-614","source":"Crossref","is-referenced-by-count":26,"title":["Low 25-OH Vitamin D is Associated with Benign Prostatic Hyperplasia"],"prefix":"10.1097","volume":"190","author":[{"given":"Mohammad-Ali","family":"Haghsheno","sequence":"first","affiliation":[{"name":"Department of Urology, Institute of Clinical Sciences, Sahlgrenska University Hospital, Goteborg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Mellstr\u00f6m","sequence":"additional","affiliation":[{"name":"Centre for Bone and Arthritis Research at the Sahlgrenska Academy, Sahlgrenska University Hospital, Goteborg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl-Johan","family":"Behre","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska Academy at Goteborg University, Goteborg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan-Erik","family":"Damber","sequence":"additional","affiliation":[{"name":"Department of Urology, Institute of Clinical Sciences, Sahlgrenska University Hospital, Goteborg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Johansson","sequence":"additional","affiliation":[{"name":"Centre for Bone and Arthritis Research at the Sahlgrenska Academy, Sahlgrenska University Hospital, Goteborg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"Karlsson","sequence":"additional","affiliation":[{"name":"Clinical and Molecular Osteoporosis Research Unit, Department of Clinical Sciences and Orthopaedic Surgery, Sk\u00e5ne University Hospital in Malm\u00f6, Lund University, Malm\u00f6, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattias","family":"Lorentzon","sequence":"additional","affiliation":[{"name":"Centre for Bone and Arthritis Research at the Sahlgrenska Academy, Sahlgrenska University Hospital, Goteborg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"Peeker","sequence":"additional","affiliation":[{"name":"Department of Urology, Institute of Clinical Sciences, Sahlgrenska University Hospital, Goteborg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabet","family":"Barret-Connor","sequence":"additional","affiliation":[{"name":"Department of Family and Preventive Medicine, University of California-San Diego, San Diego, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Waern","sequence":"additional","affiliation":[{"name":"Centre for Bone and Arthritis Research at the Sahlgrenska Academy, Sahlgrenska University Hospital, Goteborg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valter","family":"Sundh","sequence":"additional","affiliation":[{"name":"Department of Community Medicine and Public Health, Sahlgrenska University Hospital, Goteborg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claes","family":"Ohlsson","sequence":"additional","affiliation":[{"name":"Centre for Bone and Arthritis Research at the Sahlgrenska Academy, Sahlgrenska University Hospital, Goteborg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Hammarsten","sequence":"additional","affiliation":[{"name":"Section of Urology, Department of Surgery, Karlstad Central Hospital, Karlstad, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2013.01.104_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/MOU.0b013e32835abd4a","article-title":"Correlation between benign prostatic hyperplasia and inflammation","volume":"23","author":"Bostanci","year":"2013","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.juro.2013.01.104_bib2","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.eururo.2011.11.013","article-title":"The correlation between metabolic syndrome and prostatic diseases","volume":"61","author":"De Nunzio","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.01.104_bib3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.pcan.4500221","article-title":"Components of the metabolic syndrome\u2014risk factors for the development of benign prostatic hyperplasia","volume":"1","author":"Hammarsten","year":"1998","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.juro.2013.01.104_bib4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.eururo.2006.05.040","article-title":"The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia","volume":"51","author":"Ozden","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.01.104_bib5","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/pcan.2008.50","article-title":"Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia","volume":"12","author":"Hammarsten","year":"2009","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.juro.2013.01.104_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000052430","article-title":"Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia","volume":"39","author":"Hammarsten","year":"2001","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.01.104_bib7","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0022-5347(05)64687-3","article-title":"Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia","volume":"168","author":"Dahle","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.01.104_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cca.2006.01.019","article-title":"Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia","volume":"370","author":"Nandeesha","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.juro.2013.01.104_bib9","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1210\/jc.2007-0298","article-title":"Review: The role of vitamin D and calcium in type 2 diabetes: a systematic review and meta-analysis","volume":"92","author":"Pittas","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.juro.2013.01.104_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(02)09335-2","article-title":"Adiponectin and development of type 2 diabetes in the Pima Indian population","volume":"360","author":"Lindsay","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.juro.2013.01.104_bib11","first-page":"805","article-title":"Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells","volume":"54","author":"Peehl","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2013.01.104_bib12","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/sj.bjc.6603051","article-title":"Adiponectin and cancer: a systematic review","volume":"94","author":"Kelesidis","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.juro.2013.01.104_bib13","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1210\/en.2002-0210","article-title":"Inhibition of spontaneous and androgen-induced prostate growth by a nonhypercalcemic calcitriol analog","volume":"144","author":"Crescioli","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.juro.2013.01.104_bib14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1530\/eje.0.1500591","article-title":"Inhibition of prostate cell growth by BXL-628, a calcitriol analogue selected for a phase II clinical trial in patients with benign prostate hyperplasia","volume":"150","author":"Crescioli","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.juro.2013.01.104_bib15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2005.08.014","article-title":"BXL628, a novel vitamin D3 analog arrests prostate growth in patients with benign prostatic hyperplasia: a randomized clinical trial","volume":"49","author":"Colli","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.01.104_bib16","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/aje\/kwm389","article-title":"Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial","volume":"167","author":"Kristal","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.juro.2013.01.104_bib17","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0022-5347(17)38508-7","article-title":"Determination of prostate volume by transrectal ultrasound","volume":"145","author":"Terris","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.01.104_bib18","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00198-011-1809-5","article-title":"Low serum vitamin D is associated with increased mortality in elderly men: MrOS Sweden","volume":"23","author":"Johansson","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.juro.2013.01.104_bib19","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1359\/jbmr.061018","article-title":"Serum levels of specific glucuronidated androgen metabolites predict BMD and prostate volume in elderly men","volume":"22","author":"Vandenput","year":"2007","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.juro.2013.01.104_bib20","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/jbmr.1591","article-title":"High serum adiponectin predicts incident fractures in elderly men: osteoporotic fractures in men (MrOS) Sweden","volume":"27","author":"Johansson","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.juro.2013.01.104_bib21","doi-asserted-by":"crossref","first-page":"E857","DOI":"10.1111\/j.1464-410X.2012.11343.x","article-title":"Dutasteride, who is it more effective for? Second to fourth digit ratio and the relationship with prostate volume reduction by dutasteride treatment","volume":"110","author":"Kim","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2013.01.104_bib22","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1158\/1055-9965.EPI-11-0403","article-title":"Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study","volume":"20","author":"Albanes","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prevent"},{"key":"10.1016\/j.juro.2013.01.104_bib23","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1525-139X.2005.18403.x","article-title":"Vitamin D and the epidemiology of prostate cancer","volume":"18","author":"Schwartz","year":"2005","journal-title":"Semin Dialysis"},{"key":"10.1016\/j.juro.2013.01.104_bib24","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/ajcn\/67.6.1108","article-title":"Sunlight, season, skin pigmentation, vitamin D, and 25-hydroxyvitamin D: integral components of the vitamin D endocrine system","volume":"67","author":"Norman","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.juro.2013.01.104_bib25","first-page":"391","article-title":"Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3","volume":"7","author":"Schwartz","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.juro.2013.01.104_bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0960-0760(98)00054-5","article-title":"Localization of 1,25-dihydroxyvitamin D3 receptor (VDR) expression in human prostate","volume":"66","author":"Kivineva","year":"1998","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.juro.2013.01.104_bib27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4103\/0253-7613.77335","article-title":"Vitamin D as a promising anticancer agent","volume":"43","author":"Chakraborti","year":"2011","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.juro.2013.01.104_bib28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.diff.2011.04.006","article-title":"Androgens and estrogens in benign prostatic hyperplasia: past, present and future","volume":"82","author":"Nicholson","year":"2011","journal-title":"Differentiation"},{"key":"10.1016\/j.juro.2013.01.104_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006015.pub3","article-title":"Finasteride for benign prostatic hyperplasia","author":"Tacklind","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.juro.2013.01.104_bib30","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.juro.2010.05.033","article-title":"Prospective study of serum dihydrotestosterone and subsequent risk of benign prostatic hyperplasia in community dwelling men: the Rancho Bernardo Study","volume":"184","author":"Parsons","year":"2010","journal-title":"J Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534713002528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534713002528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2013.01.104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T02:57:34Z","timestamp":1651201054000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2013.01.104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["10.1016\/j.juro.2013.01.104"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2013.01.104","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}